Leigh Zawel - Chief Scientific Officer, Small Molecules at Cullinan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer, Small Molecules
Issuer Symbol
CGEM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Leigh Zawel since 11 Mar 2025

Holdings reported by Leigh Zawel for Cullinan Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 69,785 $869,521 $12.46 11 Feb 2022 Direct
Stock Option (Right to Buy) 65,000 11 Feb 2022 Direct Common Stock

Transactions reported by Leigh Zawel for Cullinan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.